{"id":32286,"date":"2025-04-23T16:33:21","date_gmt":"2025-04-23T08:33:21","guid":{"rendered":"https:\/\/flcube.com\/?p=32286"},"modified":"2025-04-23T16:33:22","modified_gmt":"2025-04-23T08:33:22","slug":"hotgen-biotech-injects-rmb-300-million-into-subsidiary-sungen-bio-for-biologic-rd","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=32286","title":{"rendered":"Hotgen Biotech Injects RMB 300 Million into Subsidiary Sungen Bio for Biologic R&amp;D"},"content":{"rendered":"\n<p>China&#8217;s Hotgen Biotech Co., Ltd (<a href=\"https:\/\/www.google.com\/finance\/quote\/688068:SHA\">SHA: 688068<\/a>) has announced a strategic capital injection plan, partnering with Green Pine Capital Partners and other institutional investors to inject RMB 300 million (USD 41 million) into its subsidiary Beijing Sungen Biomedical Technology Co., Ltd. The funds are earmarked to accelerate the research and development of Shunjing Bio&#8217;s innovative biologic therapeutics.<\/p>\n\n\n\n<p><strong>Sungen Bio&#8217;s Pipeline and Progress<\/strong><br>Sungen Bio, a clinical-stage biopharmaceutical company, has a pipeline of 10 monoclonal antibody (mAb) candidates. Its lead asset, SGC001, has advanced to a Phase Ib clinical trial for acute myocardial infarction (AMI). This investment will further support the development of its promising therapeutic candidates.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/688068_20250423_SV3G.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of 688068_20250423_SV3G.\"><\/object><a id=\"wp-block-file--media-8a18b360-fece-4705-8f49-a8eb38eeb69a\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/688068_20250423_SV3G.pdf\">688068_20250423_SV3G<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/688068_20250423_SV3G.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-8a18b360-fece-4705-8f49-a8eb38eeb69a\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>China&#8217;s Hotgen Biotech Co., Ltd (SHA: 688068) has announced a strategic capital injection plan, partnering&#8230;<\/p>\n","protected":false},"author":1,"featured_media":32290,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[20,420,1205,3889],"class_list":["post-32286","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-finance","tag-hotgen-biotech","tag-sha-688068","tag-sungen-biomedical-technology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Hotgen Biotech Injects RMB 300 Million into Subsidiary Sungen Bio for Biologic R&amp;D - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China&#039;s Hotgen Biotech Co., Ltd (SHA: 688068) has announced a strategic capital injection plan, partnering with Green Pine Capital Partners and other institutional investors to inject RMB 300 million (USD 41 million) into its subsidiary Beijing Sungen Biomedical Technology Co., Ltd. The funds are earmarked to accelerate the research and development of Shunjing Bio&#039;s innovative biologic therapeutics.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=32286\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hotgen Biotech Injects RMB 300 Million into Subsidiary Sungen Bio for Biologic R&amp;D\" \/>\n<meta property=\"og:description\" content=\"China&#039;s Hotgen Biotech Co., Ltd (SHA: 688068) has announced a strategic capital injection plan, partnering with Green Pine Capital Partners and other institutional investors to inject RMB 300 million (USD 41 million) into its subsidiary Beijing Sungen Biomedical Technology Co., Ltd. The funds are earmarked to accelerate the research and development of Shunjing Bio&#039;s innovative biologic therapeutics.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=32286\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-23T08:33:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-23T08:33:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2309.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32286#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32286\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Hotgen Biotech Injects RMB 300 Million into Subsidiary Sungen Bio for Biologic R&amp;D\",\"datePublished\":\"2025-04-23T08:33:21+00:00\",\"dateModified\":\"2025-04-23T08:33:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32286\"},\"wordCount\":126,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32286#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/2309.webp\",\"keywords\":[\"Finance\",\"Hotgen Biotech\",\"SHA: 688068\",\"Sungen Biomedical Technology\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=32286#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32286\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=32286\",\"name\":\"Hotgen Biotech Injects RMB 300 Million into Subsidiary Sungen Bio for Biologic R&amp;D - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32286#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32286#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/2309.webp\",\"datePublished\":\"2025-04-23T08:33:21+00:00\",\"dateModified\":\"2025-04-23T08:33:22+00:00\",\"description\":\"China's Hotgen Biotech Co., Ltd (SHA: 688068) has announced a strategic capital injection plan, partnering with Green Pine Capital Partners and other institutional investors to inject RMB 300 million (USD 41 million) into its subsidiary Beijing Sungen Biomedical Technology Co., Ltd. The funds are earmarked to accelerate the research and development of Shunjing Bio's innovative biologic therapeutics.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32286#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=32286\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32286#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/2309.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/2309.webp\",\"width\":1080,\"height\":608,\"caption\":\"Hotgen Biotech Injects RMB 300 Million into Subsidiary Shunjing Bio for Biologic R&D\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32286#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hotgen Biotech Injects RMB 300 Million into Subsidiary Sungen Bio for Biologic R&amp;D\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Hotgen Biotech Injects RMB 300 Million into Subsidiary Sungen Bio for Biologic R&amp;D - Insight, China&#039;s Pharmaceutical Industry","description":"China's Hotgen Biotech Co., Ltd (SHA: 688068) has announced a strategic capital injection plan, partnering with Green Pine Capital Partners and other institutional investors to inject RMB 300 million (USD 41 million) into its subsidiary Beijing Sungen Biomedical Technology Co., Ltd. The funds are earmarked to accelerate the research and development of Shunjing Bio's innovative biologic therapeutics.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=32286","og_locale":"en_US","og_type":"article","og_title":"Hotgen Biotech Injects RMB 300 Million into Subsidiary Sungen Bio for Biologic R&amp;D","og_description":"China's Hotgen Biotech Co., Ltd (SHA: 688068) has announced a strategic capital injection plan, partnering with Green Pine Capital Partners and other institutional investors to inject RMB 300 million (USD 41 million) into its subsidiary Beijing Sungen Biomedical Technology Co., Ltd. The funds are earmarked to accelerate the research and development of Shunjing Bio's innovative biologic therapeutics.","og_url":"https:\/\/flcube.com\/?p=32286","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-04-23T08:33:21+00:00","article_modified_time":"2025-04-23T08:33:22+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2309.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=32286#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=32286"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Hotgen Biotech Injects RMB 300 Million into Subsidiary Sungen Bio for Biologic R&amp;D","datePublished":"2025-04-23T08:33:21+00:00","dateModified":"2025-04-23T08:33:22+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=32286"},"wordCount":126,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=32286#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2309.webp","keywords":["Finance","Hotgen Biotech","SHA: 688068","Sungen Biomedical Technology"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=32286#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=32286","url":"https:\/\/flcube.com\/?p=32286","name":"Hotgen Biotech Injects RMB 300 Million into Subsidiary Sungen Bio for Biologic R&amp;D - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=32286#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=32286#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2309.webp","datePublished":"2025-04-23T08:33:21+00:00","dateModified":"2025-04-23T08:33:22+00:00","description":"China's Hotgen Biotech Co., Ltd (SHA: 688068) has announced a strategic capital injection plan, partnering with Green Pine Capital Partners and other institutional investors to inject RMB 300 million (USD 41 million) into its subsidiary Beijing Sungen Biomedical Technology Co., Ltd. The funds are earmarked to accelerate the research and development of Shunjing Bio's innovative biologic therapeutics.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=32286#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=32286"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=32286#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2309.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2309.webp","width":1080,"height":608,"caption":"Hotgen Biotech Injects RMB 300 Million into Subsidiary Shunjing Bio for Biologic R&D"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=32286#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Hotgen Biotech Injects RMB 300 Million into Subsidiary Sungen Bio for Biologic R&amp;D"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2309.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/32286","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=32286"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/32286\/revisions"}],"predecessor-version":[{"id":32291,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/32286\/revisions\/32291"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/32290"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=32286"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=32286"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=32286"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}